<p>Interview with Dhruv S. Kazi, MD, MSc, MS, author of <a href= "http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2016.11004"> Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease</a></p>

JAMA Professionalism: Best Practice--Disclosure of Medical Error

Go beyond the latest discoveries with nuanced, in-depth conversations in Healthy Dialogue, a podcast from the JAMA Network. Host and JAMA Senior Editor, Derek C. Angus, MD, MPH, sits down with the world's leading experts to explore the most pressing issues in health and health care.